Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,025.20
    +1,182.86 (+1.36%)
     

  • CMC Crypto 200

    1,370.83
    +58.21 (+4.43%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Global Blood Therapeutics

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / July 26, 2018 / U.S. equities closed up on Wednesday, as trade tension eased following the President Trump's statement that the U.S. and the EU will "work together toward zero tariffs, zero non-tariff barriers, zero subsidies on non auto-industrial goods." The Dow Jones Industrial Average gained 0.68 percent to close at 25,414.10, while the S&P 500 Index was up 0.91 percent to close at 2,846.07. The Nasdaq Composite Index jumped 1.17 percent to close at 7,932.24.

According to Charlie Ripley, senior investment strategist at Allianz Investment Management, "In particular, easing trade tensions on an important sector like autos is positive for both counterparts."

"The agreement to not impose new tariffs while negotiations take place is a signal that real progress could happen. In turn, markets moved away from haven assets with the 10 year Treasury yield rising 3 basis points and the S&P 500 gaining a half percent on the news. Any news considered to be progress on the trade front will likely be embraced by investors as a positive signal for risk assets," Ripley added.

RDI Initiates Coverage on:

Sarepta Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=SRPT

ADVERTISEMENT

Global Blood Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=GBT

Sarepta Therapeutics' stock moved 0.03% lower Wednesday, to close the day at $131.22. The stock recorded a trading volume of 676,973 shares, which was below its three months average volume of 1,772,907 shares. In the last year, Sarepta Therapeutics' shares have traded in a range of 32.80 - 176.50. The share price has gained 300.06% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $106.95 is above its 200-day moving average of $78.75. Shares of Sarepta Therapeutics have fallen roughly 4.73 percent in the past month and are up 135.84 percent year-to-date.

Access RDI's Sarepta Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SRPT

On Wednesday, shares of Global Blood Therapeutics recorded a trading volume of 1,193,640 shares, which was below the three months average volume of 1,234,519 shares. The stock ended the day 6.55% higher at $43.10. The share price has fallen 36.66% from its 52 week high with a 52 week trading range of 24.02 - 68.05. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $45.97 is below its 200-day moving average of $49.55. Shares of Global Blood Therapeutics have gained roughly 10.23 percent in the past month and are up 9.53 percent year-to-date.

Access RDI's Global Blood Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GBT

Our Actionable Research on Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and Global Blood Therapeutics, Inc. (NASDAQ: GBT) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com